The European Medicines Agency will review GSK's request to approve its asthma drug Nucala as an additional treatment for ...

GlaxoSmithKline’s Nucala (mepolizumab) has gained a new FDA approval for the rare autoimmune disease eosinophilic granulomatosis with polyangiitis (EGPA). Nucala, an interleukin-5 (IL-5 ...

Nucala (mepolizumab) and Dupixent (dupilumab) are brand-name subcutaneous injections. They’re both prescribed for asthma and chronic rhinosinusitis with nasal polyps. Each drug may also be ...

GSK on Monday said that the European Medicines Agency has agreed to review a request to approve the British drugmaker's ...

Nucala (mepolizumab) is a prescription injection used to treat a type of asthma and other inflammatory conditions. Nucala isn’t known to interact with other drugs, alcohol, or supplements.

The price you pay for Nucala may depend on factors such as your health or medical insurance and the pharmacy used. Financial assistance may be available to help you with the cost of Nucala.

Recent health news highlights a 10% rise in child TB infections in Europe, detected mammal bird flu cases, and economic ...

Nucala isn’t known to interact with drugs, supplements, or alcohol. However, Nucala may cause certain vaccines to be less effective. Talk with your doctor to help avoid potentially harmful ...

GSK (GSK) plc announced that the European Medicines Agency has accepted for review its application to expand the use of Nucala, a monoclonal ...

The European Medicines Agency (EMA) has agreed to review GSK’s application of expanding Nucala’s (mepolizumab) use as add-on maintenance for individuals with chronic obstructive pulmonary ...

Current health news highlights a 10% rise in child TB infections in Europe, a new drug review by European regulators, the ...

March 24 (Reuters) - The European Medicines Agency will review GSK's (GSK.L), opens new tab request to approve its asthma drug Nucala as an additional treatment for chronic obstructive pulmonary ...